Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-5345

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-5345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905345)

FDA Label Image

Figure-1 (Valsartan Hctz Figure 1)

This appears to be a chart showing the baseline systolic blood pressure (SBP) in mmHg for a clinical trial involving several medications, including Valsartan HCT 320/25mg, Valsartan 320mg, Hydrochlorothiazide 25mg, and Placebo. The chart also shows the percentage of patients with SBP lower than 140 mmHg, and provides a range for the baseline SBP from 140 to 180 mmHg, with data points at every 5 mmHg interval.*

FDA Label Image

Figure-2 (Valsartan Hctz Figure 2)

This appears to be a chart showing different blood pressure (BP) medications and their effect on diastolic blood pressure (DBP). The top line shows that all medications listed work to bring down DBP below 90 mmHg. The chart shows the brand name Valsartan and the addition of Hydrochlorothiazide (HCT) in a 320/25 mg dose. The chart also contains placebo data. The chart's baseline DBP is 105 mmHg.*

FDA Label Image

Figure-3 (Valsartan Hctz Figure 3)

This is a list of medication dosages labeled with alphanumeric codes. There is also a chart with a range of values labeled as "Baseline SBP (mmHg)." It is unclear what the context or purpose of this information is, as there is no additional information provided.*

FDA Label Image

Figure-4 (Valsartan Hctz Figure 4)

This appears to be a table showing the baseline diastolic blood pressure (DBP) values (in mmHg) for different treatment groups: Valsartan HCT 320/12.5 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. The values range from 95 to 105.*

FDA Label Image

Hctz-stru (Valsartan Hctz Hydrochlorothiazide)

FDA Label Image

Valsartan-str (Valsartan Hctz Valsartan)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.